Akoya Biosciences Investor Relations Material
Latest events
Q3 2024
Akoya Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Akoya Biosciences Inc
Access all reports
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers DyScribe In Situ Protein Synthesis Kit for in situ protein synthesis to enable scientists to study the proteome; and Akoya Preclinical, which is an in vivo visualization and signaling platform that enables scientists to visualize and precisely measure signal activation at the single cell level. It also provides Akoya XSpatial Platform for research, diagnostics, and bio-manufacturing applications. The company was founded in 2011 and is headquartered in Cambridge, Massachusetts.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
AKYA
Country
🇺🇸 United States